Cargando…
Current management and prognostic features for gastrointestinal stromal tumor (GIST)
Stromal or mesenchymal neoplasms affecting the gastrointestinal (GI) tract have undergone a remarkable evolution in how they are perceived, classified, approached, diagnosed and managed over the last 30 years. Gastrointestinal stromal tumors (GIST) account for approximately 1% to 3% of all malignant...
Autores principales: | Lamba, Gurpreet, Gupta, Ridhi, Lee, Byung, Ambrale, Samir, Liu, Delong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3514103/ https://www.ncbi.nlm.nih.gov/pubmed/23210689 http://dx.doi.org/10.1186/2162-3619-1-14 |
Ejemplares similares
-
Recent advances and novel agents for gastrointestinal stromal tumor (GIST)
por: Lamba, Gurpreet, et al.
Publicado: (2012) -
Relationship between diagnostic imaging features and prognostic outcomes in gastrointestinal stromal tumors (GIST)
por: Ginevra, Danti, et al.
Publicado: (2019) -
Clinicopathologic features and prognostic grouping of gastrointestinal stromal tumors (GISTs) in Pakistani patients: an institutional perspective
por: Hashmi, Atif Ali, et al.
Publicado: (2018) -
CT features, mimics and atypical presentations of gastrointestinal stromal tumor (GIST)
por: Sripathi, Smiti, et al.
Publicado: (2011) -
Primary omental Gastrointestinal stromal tumor (GIST)
por: Todoroki, Takeshi, et al.
Publicado: (2007)